[A late phase II study of raltitrexed (ZD 1694) in chemotherapy-naive patients with advanced colorectal cancer].

Nishisho, I; Kikkawa, N; Ebata, T; Osanai, H; Ujiie, S; Mitachi, Y; Tsutsui, M; Sawai, K; Nishiguchi, Y; Yasutake, K; Wakasugi, H; Wakui, A

Nishisho, I; Kikkawa, N; Ebata, T; Osanai, H; Ujiie, S; Mitachi, Y; Tsutsui, M; Sawai, K; Nishiguchi, Y; Yasutake, K; Wakasugi, H; Wakui, A.

Affiliation

Nishisho I; Dept. of Surgery, Osaka National Hospital.

Gan To Kagaku Ryoho ; 27(1): 81-91, 2000 Jan.

Article in Ja | MEDLINE | ID: mdl-10660737

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Colonic Neoplasms/drug therapy; Enzyme Inhibitors/therapeutic use; Quinazolines/therapeutic use; Rectal Neoplasms/drug therapy; Thiophenes/therapeutic use; Adult; Aged; Antimetabolites, Antineoplastic/adverse effects; Colonic Neoplasms/mortality; Drug Administration Schedule; Enzyme Inhibitors/adverse effects; Female; Humans; Leukopenia/chemically induced; Male; Middle Aged; Quinazolines/adverse effects; Rectal Neoplasms/mortality; Thiophenes/adverse effects; Thymidylate Synthase/antagonists & inhibitors

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Rectal Neoplasms / Thiophenes / Colonic Neoplasms / Enzyme Inhibitors / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2000 Type: Article

Search on Google

XML

PubMed Links